Disorders of hepatic gluconeogenesis and lipogenesis may lead to metabolic problems such as diabetes, dyslipidemia, and fatty liver. Our long-term goal is to investigate the mechanisms by which p38 regulates hepatic gluconeogenesis and lipogenesis, and provide new targets for the prevention and treatment of metabolic disorders such as diabetes and dyslipidemia. The specific hypothesis is that activation of p38 stimulates gluconeogenesis, while simultaneously inhibiting lipogenesis;the stimulatory role of p38 is accomplished by promoting the function of peroxisome proliferator-activated receptor gamma (PPARgamma) coactivator-1 alpha (PGC-1 alpha), while the inhibitory role of p38 is mediated by suppressing expression of the PPARgamma coactivator-1 beta (PGC-1 beta) gene. This hypothesis is based on our observations that 1) p38 is activated in liver by fasting and in isolated hepatocytes by glucagon;2) p38 stimulates expression of the PGC-1 alpha gene, but inhibits expression of the PGC-1 beta gene;3) Inhibition of p38 reduces expression of key gluconeogenic genes, while increasing expression of key lipogenic genes;and 4) The blockade of p38 leads to decreased levels of fasting plasma glucose and increased lipid levels in blood and liver.
Four specific aims are proposed to test the hypothesis.
Aim 1 : To characterize the key components by which p38 regulates transcription of the PGC-1 alpha gene in hepatic gluconeogenesis.
Aim 2 : To determine how p38 inhibits transcription of the PGC-1 beta gene in hepatic lipogenesis.
Aim 3 : To delineate the transcriptional components required for p38 regulation of the central lipogenic gene, sterol regulatory element binding protein-1c (SREBP-1c).
Aim 4 : To test the hypothesis that the blockade of p38 can reduce blood glucose levels in diabetic animals. Methods: Hepa-1c1c7 and FAO hepatoma cell lines, primary hepatocytes, and normal and diabetic C57BL/6 mouse models will be used in this study. A variety of molecular approaches will also be used. Significance: This study will provide new insight into mechanisms by which hepatic gluconeogenesis and lipogenesis are regulated. Completion of this study may provide new targets for the prevention and treatment of diabetes and lipid disorders.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
3R01DK076039-02S1
Application #
7777464
Study Section
Hepatobiliary Pathophysiology Study Section (HBPP)
Program Officer
Margolis, Ronald N
Project Start
2007-07-30
Project End
2012-06-30
Budget Start
2008-07-01
Budget End
2009-06-30
Support Year
2
Fiscal Year
2009
Total Cost
$1,680
Indirect Cost
Name
The Hamner Institutes
Department
Type
DUNS #
040052250
City
Research Triangle Park
State
NC
Country
United States
Zip Code
27709
Yang, Xuefeng; Mei, Shuang; Gu, Haihua et al. (2014) Exposure to excess insulin (glargine) induces type 2 diabetes mellitus in mice fed on a chow diet. J Endocrinol 221:469-80
Zha, Longying; Chen, Jiading; Sun, Suxia et al. (2014) Soyasaponins can blunt inflammation by inhibiting the reactive oxygen species-mediated activation of PI3K/Akt/NF-kB pathway. PLoS One 9:e107655
Mei, Shuang; Yang, Xuefeng; Guo, Huailan et al. (2014) A small amount of dietary carbohydrate can promote the HFD-induced insulin resistance to a maximal level. PLoS One 9:e100875
Yang, Xuefeng; Mei, Shuang; Wang, Xiaolei et al. (2013) Leucine facilitates insulin signaling through a G?i protein-dependent signaling pathway in hepatocytes. J Biol Chem 288:9313-20
Mei, Shuang; Gu, Haihua; Ward, Adam et al. (2012) p38 mitogen-activated protein kinase (MAPK) promotes cholesterol ester accumulation in macrophages through inhibition of macroautophagy. J Biol Chem 287:11761-8
Mei, Shuang; Gu, Haihua; Yang, Xuefeng et al. (2012) Prolonged exposure to insulin induces mitochondrion-derived oxidative stress through increasing mitochondrial cholesterol content in hepatocytes. Endocrinology 153:2120-9
Cao, Wenhong; Ning, Jie; Yang, Xuefeng et al. (2011) Excess exposure to insulin is the primary cause of insulin resistance and its associated atherosclerosis. Curr Mol Pharmacol 4:154-66
Ning, Jie; Hong, Tao; Ward, Adam et al. (2011) Constitutive role for IRE1?-XBP1 signaling pathway in the insulin-mediated hepatic lipogenic program. Endocrinology 152:2247-55
Hong, Tao; Ning, Jie; Yang, Xuefeng et al. (2011) Fine-tuned regulation of the PGC-1? gene transcription by different intracellular signaling pathways. Am J Physiol Endocrinol Metab 300:E500-7
Ning, Jie; Hong, Tao; Yang, Xuefeng et al. (2011) Insulin and insulin signaling play a critical role in fat induction of insulin resistance in mouse. Am J Physiol Endocrinol Metab 301:E391-401

Showing the most recent 10 out of 20 publications